Biotech

All Articles

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of staff

.Vir Medical's second-quarter revenues file had not been short of significant updates. The company a...

Galapagos stops briefly CAR-T tissue therapy trial over Parkinsonism scenario

.Galapagos has stopped registration in a trial of a BCMA-directed CAR-T tissue treatment, pushing th...

James Wilson leaving Penn to launch two brand new biotechs

.After more than thirty years, gene treatment innovator James Wilson M.D., Ph.D., is leaving the Uni...

3 biotechs make an effort to trump the summer months warmth through dropping staff

.As biotechs try to turn a fresh page in August, at the very least three companies have actually she...

venBio lifts $528M for fifth lifestyle scientific researches VC fund

.Expert equity capital company venBio has elevated yet another half a billion bucks to purchase biot...

Otsuka spends $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Rehabs for $800 thousand so the Japanese biote...

FibroGen lays off 75% of US personnel as resource flunks 2 more tests

.FibroGen is actually drastically restructuring its own business, giving up 75% of its USA staff as ...

Tracon wane full weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has actually made a decision to unwind procedures full weeks after an inject...

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on neglected epilepsy medication, proclaims FDA manage

.Our company already know that Takeda is wishing to locate a road to the FDA for epilepsy medication...